|
|
Volumn 49, Issue 3, 2009, Pages 1056-1057
|
|
The quest for liver fibrosis biomarkers: Promises from the enhanced liver fibrosis panel and beyond
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALPHA 2 MACROGLOBULIN;
APOLIPOPROTEIN;
APOLIPOPROTEIN L1;
BETA2 GLYCOPROTEIN 1;
BIOLOGICAL MARKER;
CD5 ANTIGEN;
COMPLEMENT FACTOR H;
CYTOKERATIN 18;
HYALURONIC ACID;
PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;
THIOESTER;
TISSUE INHIBITOR OF METALLOPROTEINASE 1;
UNCLASSIFIED DRUG;
COLLAGEN TYPE 3;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
APOPTOSIS;
AREA UNDER THE CURVE;
CELL DEATH;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HUMAN;
LETTER;
LIVER BIOPSY;
LIVER FIBROSIS;
PRIORITY JOURNAL;
BIOPSY;
LIVER;
LIVER CIRRHOSIS;
METABOLISM;
NOTE;
PATHOLOGY;
BIOLOGICAL MARKERS;
BIOPSY;
COLLAGEN TYPE III;
HUMANS;
HYALURONIC ACID;
LIVER;
LIVER CIRRHOSIS;
TISSUE INHIBITOR OF METALLOPROTEINASE-1;
|
|
EID: 63349112296
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1002/hep.22608 Document Type: Letter |
|
Times cited : (3)
|
|
References (7)
|
